ArticleClinical drug investigation2019

Cost-effectiveness of Teriflunomide Compared to Interferon Beta-1b for Relapsing Multiple Sclerosis Patients in China.

Yan Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.